文献速递老年综合评估衰弱、肌少症与跌倒

阿司匹林对社区老年人日常生活活动能力残疾的影响

Effect of Aspirin on Activities of Daily Living Disability in Community-Dwelling Older Adults.
PubMed 文献 · J Gerontol A Biol Sci Med Sci · 2021-01-01

阿司匹林未减少新发ADL残疾风险,但持续ADL残疾事件较低(4.3 vs 5.3/1000人年,HR=0.81,95%CI 0.66-1.00),持续残疾后阿司匹林组死亡更多(24 vs 12)。

要点

  • 低剂量阿司匹林未降低新发ADL残疾风险。
  • 持续ADL残疾在阿司匹林组较低(HR=0.81,95%CI 0.66-1.00)。
  • 持续ADL残疾后阿司匹林组死亡数更多(24 vs 12)。

核心结论

  • 在初始健康的社区老年人中,低剂量阿司匹林未减少新发ADL残疾风险,但有证据显示持续ADL残疾减少。

研究设计与样本

  • 每6个月评估6项基本ADL,新发ADL残疾定义为≥1项ADL无法完成或严重困难,持续定义为6个月后同一ADL残疾仍存在。

主要发现

  • 中位随访4.7年,新发ADL残疾在阿司匹林组为776/9525,安慰剂组为787/9589,最常见为行走、洗澡、穿衣和转移。
  • 仅24%的新发ADL残疾进展为持续ADL残疾。
  • 持续ADL残疾在阿司匹林组为4.3事件/1000人年,安慰剂组为5.3事件/1000人年(HR=0.81,95%CI 0.66-1.00),两组最常见持续ADL残疾均为洗澡和穿衣。
  • 持续ADL残疾后,阿司匹林组死亡24例,安慰剂组死亡12例。

关键数值与推荐

  • 新发ADL残疾定义:6项基本ADL中≥1项无法完成或严重困难。
  • 持续ADL残疾定义:新发ADL残疾6个月后同一ADL残疾仍存在。

临床怎么用

  • 对于初始健康的社区老年人,不应以预防新发ADL残疾为目的使用低剂量阿司匹林。
  • 阿司匹林可能减少持续ADL残疾,但持续残疾后死亡数更多,需个体化权衡。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Cerebrovascular events, dementia, and cancer can contribute to physical disability with activities of daily living (ADL). It is unclear whether low-dose aspirin reduces this burden in aging populations. In a secondary analysis, we now examine aspirin's effects on incident and persistent ADL disability within a primary prevention aspirin trial in community-dwelling older adults. METHODS: The ASPREE (ASPirin in Reducing Events in the Elderly) trial of daily 100 mg aspirin versus placebo recruited 19 114 healthy adults aged 70+ years (65+ years if U.S. minority) in Australia and the United States. Six basic ADLs were assessed every 6 months. Incident ADL disability was defined as inability or severe difficulty with ≥1 ADL; persistence was confirmed if the same ADL disability remained after 6 months. Proportional hazards modeling compared time to incident or persistent ADL disability for aspirin versus placebo; death without prior disability was a competing risk. RESULTS: Over a median of 4.7 years, incident ADL disability was similar in those receiving aspirin (776/9525) and placebo (787/9589) with walking, bathing, dressing, and transferring the most commonly reported. Only 24% of incident ADL disability progressed to persistent. Persistent ADL disability was lower in the aspirin group (4.3 vs 5.3 events/1000 py; hazard ratio [HR] = 0.81, 95% confidence interval [CI]: 0.66-1.00), with bathing and dressing the most common ADL disabilities in both groups. Following persistent ADL disability, there were more deaths in the aspirin group (24 vs 12). DISCUSSION: Low-dose aspirin in initially healthy older people did not reduce the risk of incident ADL disability, although there was evidence of reduced persistent ADL disability.

来源:J Gerontol A Biol Sci Med Sci,查看原文。版权归原作者所有。

引用

  1. Woods RL, Espinoza S, Thao LTP, et al. Effect of Aspirin on Activities of Daily Living Disability in Community-Dwelling Older Adults. J Gerontol A Biol Sci Med Sci. 2021. PMID: 33367621. doi:10.1093/gerona/glaa316

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。